Aastrom(美国)

Aastrom Biosciences

美国AastromBioscienceswww.aastrom.com美国AastromBiosciences,Inc.(NASDAQ:ASTM)专门从事干细胞产品研发的生物制药企业Aastromisaleaderinthedevelopmentofautologouscellproductsfortherepairorregenerationofhumantissue.TheCompany'sp roprietaryTissueRepairCell(TRC)technologyinvolvestheuseofapatient'sowncellstomanufactureproductstotreatarangeofchronicdiseasesandseriousinjuries.Aastrom'sTRC-basedproductscontainincreasednumbersofstemandearlyprogenitorcells,producedfromasmallamountofbonemarrowcollectedfromthepatient.TheTRCtechnologyplatformhaspositionedAastromtoadvancemultipleproductsintoclinicaldevelopment.TheCompany’songoingdevelopmentactivitiesfocusonapplyingTRCtechnologytocardiacandvasculartissueregeneration.APhaseIIclinicaltrialwithdilatedcardiomyopathy(DCM)patients(theIMPACT-DCMtrial)andaPhaseIIbclinicaltrialwithcriticallimbischemia(CLI)patients(theRESTO